Medicine and Health
Spatial proteomics identifies JAKi as treatment for a lethal skin disease
T. M. Nordmann, H. Anderton, et al.
A groundbreaking study by Thierry M. Nordmann and colleagues reveals that targeting JAK inhibitors could be a transformative therapy for toxic epidermal necrolysis (TEN), a severe drug-induced skin reaction. Through deep visual proteomics analysis, the research identified key activation signatures in TEN, demonstrating the promise of JAK inhibitors in improving patient outcomes.
~3 min • Beginner • English
Related Publications
Explore these studies to deepen your understanding of the subject.

